QuidelOrtho Corp. is weighing a sale of its transfusion medicine unit, which could be valued at $1.5 billion to $2 billion, people with knowledge of the matter said. The San Diego, California-based diagnostics company is working with advisers to gauge potential interest in the unit, according to the people. The business is likely to attract interest from both strategic and private equity suitors, they said. Deliberations are in the early stages and there’s no certainty that QuidelOrtho will decide to proceed with a sale of the unit, the people said, asking not to be identified discussing confidential information.
Read the full article: QuidelOrtho Is Said to Weigh Sale of Transfusion Medicine Unit //